Role of KATP channels in the maintenance of ventricular fibrillation in cardiomyopathic human hearts

Circulation Research

Volumn 109, Issue 11, 2011, Pages 1309-1318

  Farid, Talha A ^a   Nair, Krishnakumar ^a   Massé, Stephéne ^a   Azam, Mohammed Ali ^a   Maguy, Ange ^e   Lai, Patrick F H ^a   Umapathy, Karthikeyan ^a,b   Dorian, Paul ^c   Chauhan, Vijay ^a   Varró, András ^d   Al Hesayen, Abdul ^c   Waxman, Menashe ^a   Nattel, Stanley ^e   Nanthakumar, Kumaraswamy ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b RYERSON UNIVERSITY   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF SZEGED   (Hungary)

^e MONTREAL HEART INSTITUTE   (Canada)

Author keywords

!ventricular fibrillation; arrhythmia; glibenclamide; potassium channels

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; GLIBENCLAMIDE; LIDOCAINE; PINACIDIL; MESSENGER RNA;

ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATION; ENDOCARDIUM; EPICARDIUM; GENE EXPRESSION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HUMAN; HUMAN TISSUE; ISOLATED HEART; PRIORITY JOURNAL; PROTEIN EXPRESSION; ACTION POTENTIAL; ANIMAL; ARTIFICIAL HEART PACEMAKER; BIOSYNTHESIS; CONGESTIVE CARDIOMYOPATHY; DRUG EFFECT; IN VITRO STUDY; MALE; METABOLISM; PATHOPHYSIOLOGY; PERFUSION; PERICARDIUM; PHYSIOLOGY; RAT; REFRACTORY PERIOD; SPRAGUE DAWLEY RAT;

ACTION POTENTIALS; ANIMALS; CARDIOMYOPATHY, DILATED; ENDOCARDIUM; GLYBURIDE; HUMANS; KATP CHANNELS; LIDOCAINE; MALE; MYOCARDIAL ISCHEMIA; PACEMAKER, ARTIFICIAL; PERFUSION; PERICARDIUM; RATS; RATS, SPRAGUE-DAWLEY; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; RNA, MESSENGER; VENTRICULAR FIBRILLATION;

EID: 81355127487     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.110.232918     Document Type: Article

References (46)

1. Baker LC, London B, Choi BR, Koren G, Salama G. Enhanced dispersion of repolarization and refractoriness in transgenic mouse hearts promotes reentrant ventricular tachycardia. Circ Res. 2000;86:396-407 (Pubitemid 30141758)
2. el-Sherif N, Gough WB, Restivo M. Reentrant ventricular arrhythmias in the late myocardial infarction period: mechanism by which a short-long-short cardiac sequence facilitates the induction of reentry. Circulation. 1991;83:268-278.
3. Frazier DW, Wolf PD, Wharton JM, Tang AS, Smith WM, Ideker RE. Stimulus-induced critical point: mechanism for electrical initiation of reentry in normal canine myocardium. J Clin Invest. 1989;83: 1039-1052. (Pubitemid 19080639)
4. Wit AL, Allessie MA, Bonke FI, Lammers W, Smeets J, Fenoglio JJ Jr. Electrophysiologic mapping to determine the mechanism of experimental ventricular tachycardia initiated by premature impulses: experimental approach and initial results demonstrating reentrant excitation. Am J Cardiol. 1982;49:166-185. (Pubitemid 12003521)
5. Downar E, Janse MJ, Durrer D. The effect of acute coronary artery occlusion on subepicardial transmembrane potentials in the intact porcine heart. Circulation. 1977;56:217-224. (Pubitemid 8247479)
6. Isidoro Tavares N, Philip-Couderc P, Papageorgiou I, Baertschi AJ, Lerch R, Montessuit C. Expression and function of ATP-dependent potassium channels in late post-infarction remodeling. JMol Cell Cardiol. 2007;42: 1016-1025. (Pubitemid 46829203)
7. Farid TA, Nair K, Bingolis O, Masse S, Sivagangabalan G, Umapathy K, Asta J, Varro A, Nattel S, Demolombe S, Nanthakumar K. Attenuation of ischemic left ventricular dominant frequency gradient by a Katp channel blocker: an anti-arrhythmic strategy for human ventricular fibrillation. Canadian Cardiovascular Congress. Montreal, QC, Canada, October 6, 2010.
8. Toal SC, Farid TA, Selvaraj R, Chauhan VS, Masse S, Ivanov J, Harris L, Downar E, Franz MR, Nanthakumar K. Short-term memory and restitution during ventricular fibrillation in human hearts: an in vivo study. Circ Arrhythm Electrophysiol. 2009;2:562-570.
9. Misier AR, Opthof T, van Hemel NM, Vermeulen JT, de Bakker JM, Defauw JJ, van Capelle FJ, Janse MJ. Dispersion of 'refractoriness' in noninfarcted myocardium of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction. Circulation. 1995;91: 2566-2572.
10. Lammers W, Allessie M, Rensma P, Schalij M. The use of fibrillation cycle length to determine spatial dispersion in electrophysiological properties and to characterize the underlying mechanism of fibrillation. New Trends Arrhythmias. 1986;2:109-112.
11. Opthof T, Misier AR, Coronel R, Vermeulen JT, Verberne HJ, Frank RG, Moulijn AC, van Capelle FJ, Janse MJ. Dispersion of refractoriness in canine ventricular myocardium: effects of sympathetic stimulation. Circ Res. 1991;68:1204-1215.
12. Misier AR, Opthof T, van Hemel NM, Defauw JJ, de Bakker JM, Janse MJ, van Capelle FJ. Increased dispersion of "refractoriness" in patients with idiopathic paroxysmal atrial fibrillation. J Am Coll Cardiol. 1992; 19:1531-1535.
13. Opthof T, Coronel R, Shander G, Wilms-Schopman F, Janse M. Electrophysiological changes and ventricular fibrillation in acute regional ischemia in the porcine heart: the concept of wavelength. J Cardiovasc Electrophysiol. 1992;3:128-140.
14. Opthof T, Dekker L, Coronel R, Vermeulen J, Van Capelle F, Janse M. Interaction of sympathetic and parasympathetic stimulation on ventricular refractoriness assessed by local fibrillation intervals in the canine heart. Cardiovasc Res. 1993;27:753-759. (Pubitemid 23162668)
15. Wiggers CJ. The mechanism and nature of ventricular fibrillation. Am Heart J. 1940;20:399-412.
16. Patt MV, Podrid PJ, Friedman PL, Lown B. Spontaneous reversion of ventricular fibrillation. Am Heart J. 1988;115:919-923. (Pubitemid 18093168)
17. Nair K, Umapathy K, Downar E, Nanthakumar K. Aborted sudden death from sustained ventricular fibrillation. Heart Rhythm. 2008;5: 1198-1200.
18. Josephson ME, Spielman SR, Greenspan AM, Horowitz LN. Mechanism of ventricular fibrillation in man: observations based on electrode catheter recordings. Am J Cardiol. 1979;44:623-631. (Pubitemid 10246969)
19. Olsson SB, Cotoi S, Varnauskas E. Monophasic action potential and sinus rhythm stability after conversion of atrial fibrillation. Acta Med Scand. 1971;190:381-387.
20. Gavrilescu S, Cotoi S. Monophasic action potential of right human atrium during atrial flutter and after conversion to sinus rhythm: argument for re-entry theory. Br Heart J. 1972;34:396-402.
21. Chen CC, Lin YC, Chen SA, Luk HN, Ding PY, Chang MS, Chiang CE. Shortening of cardiac action potentials in endotoxic shock in guinea pigs is caused by an increase in nitric oxide activity and activation of the adenosine triphosphate-sensitive potassium channel. Crit Care Med. 2000;28:1713-1720. (Pubitemid 30428718)
22. Nakaya H, Takeda Y, Tohse N, Kanno M. Effects of ATP-sensitive K + channel blockers on the action potential shortening in hypoxic and ischaemic myocardium. Br J Pharmacol. 1991;103:1019-1026.
23. Worley SJ, Swain JL, Colavita PG, Smith WM, Ideker RE. Development of an endocardial-epicardial gradient of activation rate during electrically induced, sustained ventricular fibrillation in dogs. Am J Cardiol. 1985; 55:813-820. (Pubitemid 15148266)
24. Wu TJ, Lin SF, Hsieh YC, Ting CT, Chen PS. Ventricular fibrillation during no-flow global ischemia in isolated rabbit hearts. J Cardiovasc Electrophysiol. 2006;17:1112-1120.
25. Cha YM, Uchida T, Wolf PL, Peters BB, Fishbein MC, Karagueuzian HS, Chen PS. Effects of chemical subendocardial ablation on activation rate gradient during ventricular fibrillation. Am J Physiol. 1995;269: H1998-H2009. (Pubitemid 26023216)
26. Masse S, Farid T, Dorian P, Umapathy K, Nair K, Asta J, Ross H, Rao V, Sevaptsidis E, Nanthakumar K. Effect of global ischemia and reper-fusion during ventricular fibrillation in myopathic human hearts. Am J Physiol Heart Circ Physiol. 2009;297:H1984-H1991.
27. Miyoshi S, Miyazaki T, Asanagi M, Moritani K, Ogawa S. Differential role of epicardial and endocardial K(ATP) channels in potassium accumulation during regional ischemia induced by embolization of a coronary artery with latex. J Cardiovasc Electrophysiol. 1998;9: 292-298. (Pubitemid 28180466)
28. Zheng X, Walcott GP, Smith WM, Ideker RE. Evidence that activation following failed defibrillation is not caused by triggered activity. J Cardiovasc Electrophysiol. 2005;16:1200-1205.
29. Glukhov AV, Flagg TP, Fedorov VV, Efimov IR, Nichols CG. Differential K(ATP) channel pharmacology in intact mouse heart. J Mol Cell Cardiol. 2009;48:152-160.
30. Inagaki N, Gonoi T, Clement JP, Wang CZ, Aguilar-Bryan L, Bryan J, Seino S. A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels. Neuron. 1996;16: 1011-1017. (Pubitemid 26171205)
31. Shi NQ, Ye B, Makielski JC. Function and distribution of the SUR isoforms and splice variants. J Mol Cell Cardiol. 2005;39:51-60. (Pubitemid 40836044)
32. Babenko AP, Gonzalez G, Aguilar-Bryan L, Bryan J. Reconstituted human cardiac KATP channels: functional identity with the native channels from the sarcolemma of human ventricular cells. Circ Res. 1998;83:1132-1143. (Pubitemid 28533522)
33. Zhang H, Flagg TP, Nichols CG. Cardiac sarcolemmal K(ATP) channels: latest twists in a questing tale! J Mol Cell Cardiol. 48:71-75.
34. Lee SY, Lee CO. Inhibition of Na +-K+ pump and l-type Ca2+ channel by glibenclamide in guinea pig ventricular myocytes. J Pharmacol Exp Ther. 2005;312:61-68. (Pubitemid 40096453)
35. Morley GE, Anumonwo JM, Delmar M. Effects of 2,4-dinitrophenol or low [ATP]i on cell excitability and action potential propagation in guinea pig ventricular myocytes. Circ Res. 1992;71:821-830.
36. Feld GK, Chen PS, Nicod P, Fleck RP, Meyer D. Possible atrial proar-rhythmic effects of class 1C antiarrhythmic drugs. Am J Cardiol. 1990; 66:378-383. (Pubitemid 20235770)
37. Hohnloser SH, Klingenheben T, Singh BN. Amiodarone-associated proarrhythmic effects: a review with special reference to torsade de pointes tachycardia. Ann Intern Med. 1994;121:529-535.
38. Selzer A, Wray HW. Quinidine syncope: paroxysmal ventricular fibrillation occurring during treatment of chronic atrial arrhythmias. Circulation. 1964;30:17-26.
39. Ruskin JN, McGovern B, Garan H, DiMarco JP, Kelly E. Antiarrhythmic drugs: a possible cause of out-of-hospital cardiac arrest. N Engl J Med. 1983;309:1302-1306. (Pubitemid 14201587)
40. Zipes DP. Proarrhythmic effects of antiarrhythmic drugs. Am J Cardiol. 1987;59:26E-31E.
41. Lau DH, Clausen C, Sosunov EA, Shlapakova IN, Anyukhovsky EP, Danilo P Jr, Rosen TS, Kelly C, Duffy HS, Szabolcs MJ, Chen M, Robinson RB, Lu J, Kumari S, Cohen IS, Rosen MR. Epicardial border zone overexpression of skeletal muscle sodium channel Skm1 normalizes activation, preserves conduction, and suppresses ventricular arrhythmia: an in silico, in vivo, in vitro study. Circulation. 2009; 119:19-27.
42. Gogelein H, Hartung J, Englert HC, Scholkens BA. Hmr 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel, I: effects on cardiomyocytes, coronary flow and pancreatic beta-cells. J Pharmacol Exp Ther. 1998;286:1453-1464.
43. Wirth KJ, Klaus E, Englert HG, Scholkens BA, Linz W. Hmr 1883, a cardioselective K(ATP) channel blocker, inhibits ischaemia-and reperfusion-induced ventricular fibrillation in rats. Naunyn Schmie-debergs Arch Pharmacol. 1999;360:295-300.
44. Billman GE, Englert HC, Scholkens BA. Hmr 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel, II: effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs. J Pharmacol Exp Ther. 1998;286: 1465-1473.
45. Duytschaever M, Mast F, Killian M, Blaauw Y, Wijffels M, Allessie M. Methods for determining the refractory period and excitable gap during persistent atrial fibrillation in the goat. Circulation. 2001;104: 957-962. (Pubitemid 32778050)
46. Robertson PG, Huang J, Chen KA, Chen X, Dosdall DJ, Tabereaux PB, Smith WM, Ideker RE. Increased cycle length during long-duration ventricular fibrillation is caused by decreased upstroke velocity as well as prolonged refractoriness. Heart Rhythm. 2009;6:378-384.